References
- Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiologic study in Örebro, Sweden, 1993–1998. Gut 2004;53:346–50.
- Wickbom A NN, Eriksson S, Bohr J, Tysk C. Stable incidences of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999–2008. Gut 2009;58.
- Pardi DS, Loftus EV Jr., Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007;56:504–8.
- Warren BF, Edwards CM, Travis SP. “Microscopic colitis”: classification and terminology. Histopathology 2002;40:374–6.
- Madisch A, Heymer P, Voss C, Wigginghaus B, Bästlein E, Bayerdörffer E, Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005;20:312–16.
- Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009;104:235–41.
- Miehlke S, Madisch A, Voss C, Morgner A, Heymer P, Kuhlisch E, Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005;22:1115–19.
- Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 2009;58:68–72.
- Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001;120:1483–4.
- Riddell J, Hillman L, Chiragakis L, Clarke A. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol 2007;22:1589–93.
- Dupuy HJ. The Psychological General Well-Being (PGWBI) Index. In Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. Washington, DC, USA: Le Jacq Publishing, Inc; 1984. pp 170–83.
- Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol 2006;41:1196–203.
- Hjortswang H, Tysk C, Bohr J, Benoni C, Kilander A, Larsson L, Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 2009;15:1875–81.
- Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008;135:1510–16.
- Tagkalidis P, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007;60:382–7.
- Münch A, Söderholm JD, Ost A, Ström M. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol 2009;104:679–85.